- Trials with a EudraCT protocol (200)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (76)
200 result(s) found for: Urinary Tract Infection.
Displaying page 1 of 10.
EudraCT Number: 2016-004486-37 | Sponsor Protocol Number: 59812 | Start Date*: 2017-09-19 | ||||||||||||||||
Sponsor Name:University Medical Centre Utrecht | ||||||||||||||||||
Full Title: FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment | ||||||||||||||||||
Medical condition: Acute febrile urinary tract infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004594-82 | Sponsor Protocol Number: CSU11001 | Start Date*: 2012-01-17 | ||||||||||||||||
Sponsor Name:Schur Pharmazeutika GmbH & Co. KG | ||||||||||||||||||
Full Title: Efficacy of an intravesical instillation with neomycin solution in acute cystitis: a double-blind, placebo-controlled trial in patients with permanent intravesical catheter | ||||||||||||||||||
Medical condition: Treatment of urinary tract infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005559-19 | Sponsor Protocol Number: FUR-03-17 | Start Date*: 2021-02-23 | ||||||||||||||||||||||||||
Sponsor Name:ADAMED Pharma S.A. | ||||||||||||||||||||||||||||
Full Title: FRUTI - a phase III, randomized, multicenter, double-blind, active control study to evaluate the efficacy and safety of Furazidin prolonged-release tablets, 200 mg compared with Nitrofurantoin prol... | ||||||||||||||||||||||||||||
Medical condition: uncomplicated lower urinary tract infections (acute or recurrent) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: PL (Completed) HU (Completed) DE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000963-54 | Sponsor Protocol Number: FUR-PKPD-05-20 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:Adamed Pharma S.A. | ||||||||||||||||||||||||||||
Full Title: Effectiveness and pharmacokinetic /pharmacodynamic study of Furazidin, prolonged- release tablets, 200 mg in the treatment of patients with uncomplicated lower urinary tract infections (acute or re... | ||||||||||||||||||||||||||||
Medical condition: uncomplicated lower urinary tract infections (acute or recurrent) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: PL (Prematurely Ended) DE (Prematurely Ended) HU (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002390-13 | Sponsor Protocol Number: notapplicable | Start Date*: 2009-04-08 | |||||||||||
Sponsor Name:University Hospital | |||||||||||||
Full Title: Are cranberry capsules useful in preventing urinary tract infection in hip fracture patients with urinary tract catheter | |||||||||||||
Medical condition: Urinary tract infections in patients with hip fractures. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005112-37 | Sponsor Protocol Number: J&P 01/2007 draft4 | Start Date*: 2008-08-21 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Abteilung für Interne Medizin I | |||||||||||||
Full Title: An randomized, controlled, investigator-blinded, prospective, mono-centre study to evaluate the efficacy of fosfomycin versus meropenem in patients with complicated urinary tract infections | |||||||||||||
Medical condition: This study will primarily address the question of the efficacy of intravenous fosfomycin 4 g b.i.d. in the therapy of patients presenting with complicated urinary tract infection. These data will b... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004397-62 | Sponsor Protocol Number: PI070274 | Start Date*: 2008-11-28 | |||||||||||
Sponsor Name:Servicio Andaluz de Salud | |||||||||||||
Full Title: Análisis aleatorizado y doble ciego sobre la utilidad del extracto de arándano rojo vs profilaxis antibiótica con Trimetoprima en la infección urinaria recurrente infantil | |||||||||||||
Medical condition: First clinical assay so far where the convenience is evaluated of carrying out prophylaxis of the pediatric urinary recurrent infection in the childhood with extract of cranberries (with a fixed co... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002214-14 | Sponsor Protocol Number: IHO-0000-REN-0220-S | Start Date*: 2022-12-19 | |||||||||||
Sponsor Name:Klinikum rechts der Isar, Technische Universität München | |||||||||||||
Full Title: Individualized homeopathy to reduce the use of antibiotics in women with recurring uncomplicated urinary tract infections | |||||||||||||
Medical condition: Women with recurring uncomplicated urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001427-30 | Sponsor Protocol Number: 276046 | Start Date*: 2016-06-28 | |||||||||||
Sponsor Name:University of Helsinki / CLUE Working Group | |||||||||||||
Full Title: Antibiotic prophylaxis before extracorporeal shock wave lithotripsy (APPEAL) | |||||||||||||
Medical condition: Prevention of urinary tract infections among patients undergoing extracorporeal shock wave lithotripsy for urinary stone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005912-41 | Sponsor Protocol Number: TMO-07001 | Start Date*: 2010-05-04 | ||||||||||||||||
Sponsor Name:Belpharma SA/NV | ||||||||||||||||||
Full Title: Temocillin use in Complicated Urinary Tract Infections due to ESBL producing and AmpC hyperproducing Enterobacteriaceae in United Kingdom | ||||||||||||||||||
Medical condition: Patients presenting urinary tract infections due to Extended Spectrum Beta-Lactamases producing or AmpC hyperproducing Enterobacteriaceae. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002271-42 | Sponsor Protocol Number: 20110512-BG | Start Date*: 2011-10-13 | |||||||||||
Sponsor Name:University Medical Center Goettingen | |||||||||||||
Full Title: | |||||||||||||
Medical condition: uncomplicated urinary tract infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007742-35 | Sponsor Protocol Number: FINA-003 | Start Date*: 2008-10-01 | |||||||||||
Sponsor Name:MerLion Pharmaceuticals GmbH | |||||||||||||
Full Title: A double-blind, double-dummy, prospective, randomized multiple-site study of oral Finafloxacin 300 mg b.i.d. versus oral Ciprofloxacin 250 mg b.i.d. in patients with lower uncomplicated UTI (uUTI) ... | |||||||||||||
Medical condition: Lower uncomplicated Urinary Tract Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001486-21 | Sponsor Protocol Number: 276046 | Start Date*: 2021-11-26 | |||||||||||
Sponsor Name:University of Helsinki/CLUE working Group | |||||||||||||
Full Title: A Multicentre Randomised Control Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on reducing Urinary Tract Infections | |||||||||||||
Medical condition: Nephrolithiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004842-27 | Sponsor Protocol Number: Repha_1398 | Start Date*: 2018-07-17 | ||||||||||||||||
Sponsor Name:Repha GmbH | ||||||||||||||||||
Full Title: Clinical Trial to investigate the efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in the prophylaxis of catheter associated urinary tract infections | ||||||||||||||||||
Medical condition: Prophylaxis of catheter-associated chronically inflammatory recurring urinary tract infections in adult patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001481-42 | Sponsor Protocol Number: ITFE-2026-C11 | Start Date*: 2018-10-04 | |||||||||||
Sponsor Name:ITF RESEARCH PHARMA S.L.U. | |||||||||||||
Full Title: Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a 0.005% estriol vaginal gel in the prevention of recurrent urinary tract infection... | |||||||||||||
Medical condition: Recurrent Urinary Tract Infection (UTI) in postmenopausal women with vaginal atrophy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000914-76 | Sponsor Protocol Number: 1409R2121 | Start Date*: 2014-11-24 | |||||||||||
Sponsor Name:Shionogi Inc. | |||||||||||||
Full Title: A Multicenter, Double-blind, Randomized, Clinical Study to Assess the Efficacy and Safety of Intravenous S-649266 in Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Unc... | |||||||||||||
Medical condition: Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis caused by Gram-negative Pathogens | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) IT (Completed) ES (Completed) DE (Completed) PL (Completed) RO (Completed) HR (Completed) LV (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002747-14 | Sponsor Protocol Number: OF_FUM_CT1 | Start Date*: 2021-05-24 | |||||||||||
Sponsor Name:"Olainfarm" AS | |||||||||||||
Full Title: A multi-center, randomized, double-blind, double-dummy, parallel-group, active drug controlled, adaptive, Phase III study to investigate efficacy, safety and tolerability of Furamag (Furaginum solu... | |||||||||||||
Medical condition: Microbiologically confirmed acute uncomplicated lower urinary tract infections in women. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000545-78 | Sponsor Protocol Number: Rempex-505 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Rempex Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CARBAVANCE™ (MEROPENEM/RPX7009) COMPARED TO PIPERACILLIN/TAZOBACTAM IN TH... | ||||||||||||||||||
Medical condition: complicated urinary tract infection (cUTI) or acute pyelonephritis (AP) with or without concurrent bacteremia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) SK (Completed) IT (Completed) ES (Completed) PL (Completed) SI (Completed) BG (Completed) GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001769-35 | Sponsor Protocol Number: OYS042020. | Start Date*: Information not available in EudraCT |
Sponsor Name:Oulu University Hopsital | ||
Full Title: Preventing urinary tract infections in infants and young children with probiotic E. coli Nissle: FinNiss- trial | ||
Medical condition: Urinary tract infection | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002207-26 | Sponsor Protocol Number: TP-434-021 | Start Date*: 2016-12-15 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared with Ertapenem in Complicated Urinary Tract Infections | |||||||||||||
Medical condition: Complicated Urinary Tract Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) AT (Completed) SK (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.